Figure 1. Survival analyses for each CMG based on 539 patients with ccRCC from the TCGA database. (A) SCARB1; (B) HMGCS1; (C) HMGCR; (D) SREBF2; (E) CYP27A1; (F) ABCA1; (G) LDLR; (H) CYP7A1; (I) SOAT1; (J) SOAT2. Kaplan-Meier curves with p < 0.05 showed a significant difference in survival probability to ccRCC patients.